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Introduction: Cell supplementation to the herniated or degenerated intervertebral disc (IVD) is a potential strategy to
promote tissue regeneration and slow disc pathology. Human umbilical cord mesenchymal stromal cells (HUCMSCs) –
originating from the Wharton’s jelly – remain an attractive candidate for such endeavors with their ability to differentiate
into multiple lineages. Previously, mesenchymal stem cells (MSCs) have been studied as a potential source for disc tissue
regeneration. However, no studies have demonstrated that MSCs can regenerate matrix with unique characteristics
matching that of immature nucleus pulposus (NP) tissues of the IVD. In our prior work, immature NP cells were found to
express specific laminin isoforms and laminin-binding receptors that may serve as phenotypic markers for evaluating MSC
differentiation to NP-like cells. The goal of this study is to evaluate these markers and matrix synthesis for HUCMSCs
cultured in a laminin-rich pseudo-three-dimensional culture system.
Methods: HUCMSCs were seeded on top of Transwell inserts pre-coated with Matrigel™, which contained mainly
laminin-111. Cells were cultured under hypoxia environment with three differentiation conditions: NP differentiation
media (containing 2.5% Matrigel™ solution to provide for a pseudo-three-dimensional laminin culture system) with no
serum, or the same media supplemented with either insulin-like growth factor-1 (IGF-1) or transforming growth factor-β1
(TGF-β1). Cell clustering behavior, matrix production and the expression of NP-specific laminin and laminin-receptors were
evaluated at days 1, 7, 13 and 21 of culture.
Results: Data show that a pseudo-three-dimensional culture condition (laminin-1 rich) promoted HUCMSC differentiation
under no serum conditions. Starting at day 1, HUCMSCs demonstrated a cell clustering morphology similar to that of
immature NP cells in situ and that observed for primary immature NP cells within the similar laminin-rich culture system
(prior study). Differentiated HUCMSCs under all conditions were found to contain glycosaminoglycan, expressed
extracellular matrix proteins of collagen II and laminin α5, and laminin receptors (integrin α3 and β4 subunits). However,
neither growth factor treatment generated distinct differences in NP-like phenotype for HUCMSC as compared with no-
serum conditions.
Conclusions: HUCMSCs have the potential to differentiate into cells sharing features with immature NP cells in a laminin-
rich culture environment and may be useful for IVD cellular therapy.* Correspondence: junchen@duke.edu
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The nucleus pulposus (NP) of the intervertebral disc
(IVD) consists of a soft proteoglycan-rich gel possessing
high fluid retention capacity. With aging, the NP becomes
increasingly dehydrated and may displace or extrude from
the IVD due to material failure [1]. This degeneration and
associated pathology may manifest back or leg pain or
other spine-related disorders [2]. With a very low cell
density that decreases with age, the NP itself is not readily
capable of self-repair. Furthermore, current treatment
options provide only temporary pain relief and may
even require invasive procedures [3]. In response to
this challenge, cell supplementation to the herniated or
degenerated IVD has been explored as a means for
stimulating tissue regeneration and hampering disc path-
ology. In the past decades, many cell sources including
autologous chondrocytes and primary IVD cells have been
evaluated in clinical or preclinical trials for supplements
to promote IVD tissue regeneration [4-6]. However, few
sources of healthy autologous cells have been identified
except only a small quantity of NP progenitor cells recently
confirmed in both young and aged NP tissues [7].
Alternatively, mesenchymal stem cells (MSCs) have been
explored as a potential cell source for IVD tissue regener-
ation [8]. In general, MSCs are capable of differentiating
into various cell lineages such as cartilage, bone, adipose tis-
sue and muscle [9,10], and have also shown a potential for
reconstructive therapy in orthopedics [11,12]. In the studies
of animal models, the transplanting of bone marrow MSCs
within hyaluronan gel into rat IVDs and the implantation of
atelocollagen-enveloped MSCs into a rabbit IVDs were
found to correlate with an increase in disc height and matrix
production as compared with no-MSC gels only [13-15].
Recently, MSCs transplanted with fibrous gelatin-
transforming growth factor (TGF)-β1 were found to impede
apoptosis, thereby maintaining NP cell numbers in the rat
IVDs [16]. Similarly, bone marrow MSCs may differentiate
into NP-like or chondrocyte-like cells in vitro, in alginate
three-dimensional culture or in contact with chitosan
hydrogels [17-19]. In addition, soluble factors released by
NP cells or tissues were found to promote bone marrow
MSC differentiation into NP-like cells in vitro using condi-
tion medium [20,21] and co-culture methods [22,23]. These
aforementioned studies show the importance of interactions
between bone marrow-derived MSCs cells and the micro-
environment for regulating the NP-like phenotype.
Although MSCs from bone marrow source are plentiful,
the means of extraction prove somewhat invasive. There
is a great clinical advantage to use MSCs derived from the
source of waste tissue. It is now known that sufficient
quantities of human MSCs bearing multilineage potential
can also be obtained from the Wharton’s jelly of the
umbilical cord [24], which is usually discarded after
birth. Human umbilical cord mesenchymal stromal cells(HUCMSCs) – originating from Wharton’s jelly – are
relatively easy to cultivate in vitro, have properties that are
similar to bone marrow MSCs, express many typical MSC
markers (that is, CD29, CD44, CD73, CD90, CD105,
CD166, HLA-1) [24], and can differentiate into multiple
cell types, such as fibrocartilage [25], cartilage [26], bone
[27], neuron [28] and muscle [29]. HUCMSCs also have
another advantage of eliciting less immune response during
allogeneic transplantation [30]. Of relevance to IVD cell
regeneration, HUCMSCs were already found to differenti-
ate into NP-like cells with higher collagen gene expression
when co-cultured with human NP cells in vitro [31]. There
still remains a great need, however, to demonstrate the
capability of HUCMSCs to regenerate matrix bearing the
unique qualities, the unique cell morphology, and the
expression of molecular phenotype/marker matching that
of immature NP native tissue.
Immature NP cells originally derived from notochord
display distinct morphologic and molecular phenotypes.
Notochordal-like NP cells are larger, with vacuoles, abun-
dant cytoplasmic filaments and higher fluorescence as
compared with anulus fibrosus cells [32-34]. Several
protein markers of NP cells have been suggested, including
higher expression of cytokeratin-8 and cytokeratin-19,
vimentin, N-cadherin, brachyury, HIF-1α, glucose trans-
porter-1, matrix metalloproteinase-2, CD24, CD44, CD56,
galectin-1, type II collagen and aggrecan in NP cells as
compared with the neighboring anulus fibrosus cells in
IVD tissues [35-42]. Particularly, our group has further
discovered that immature NP cells reside in a unique
extracellular matrix (ECM) environment rich in laminin
and that they express high levels of laminin-binding recep-
tors as compared with the surrounding anulus fibrosus
cells [43-45]. In general, immature NP cells (rat, porcine
and human) expressed higher levels of integrin subunits
α1, α6, β1 and CD239, and higher levels of specific lam-
inin isoforms, LM-511 and LM-322 [44-46]. Functionally,
immature porcine NP cells were also shown to interact
with laminins predominantly through α6 and β1 integrin
subunits [44], and spread significantly more on and adhered
with greater strength to laminins (LM-511 and LM-111)
as compared with collagen II or fibronectin [46]. Most
importantly, both laminin ligand and substrate stiffness
modulates immature porcine NP cell clustering behavior
on laminin-functionalized gels [47]. Together, our previous
findings not only suggest that laminin-rich and soft sub-
strate culture conditions may mimic an immature NP native
tissue environment and promote stem cell differentiation to
NP-like cells, but also indicate that laminin and its receptors
may be useful markers for distinguishing NP-like matrix
from cell regeneration. In addition, the cell clustering be-
havior of NP cells may be a useful feature for distinguishing
the NP-like cell phenotype during cell regeneration. In this
study, we report that HUCMSCs maintained in a laminin-
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to exhibit immature NP-like cell phenotype (cell clustering
and expressing laminin receptors) and express unique
matrix proteins (type II collagen and a specific laminin iso-
form, LM-511) to NP cells.
Materials and methods
Cell culture and flow cytometry analysis
HUCMSCs (passage 2 cells; ScienCell Research Labora-
tories, Carlsbad, CA, USA) from the Wharton’s jelly of
umbilical cords were seeded (5,000 cells/cm2) and allowed
to proliferate in MSC medium (ScienCell) with 5% fetal
bovine serum (ScienCell) and MSC growth supplement
(ScienCell) at 37°C and 21% oxygen. All of the following
experiments used the same batch of cells, which were
isolated from pooled multiple donors (>3) according to
the manufacturer’s instructions. Cells were cultured to
passage 3 or passage 5. At confluence, passage 3 and
passage 5 cells were detached from the culture surface
using 0.025% trypsin/ethylenediaminetetraacetic acid
(Cambrex, East Rutherford, NJ, USA) and resuspended
in culture medium prior to antibody labeling. Cells
((0.25 to 0.5) × 106) were incubated with monoclonal
antibodies against CD31, CD34, CD44, CD45, CD90,
CD105, CD166, Lutheran glycoprotein (CD239; AbD
Serotec, Oxford, UK), integrin subunits α3 (Chemicon,
Temecula, CA, USA), β1 (Beckman Coulter, Fullerton,
CA, USA), α6 and β4 (BD Pharmingen, San Diego, CA,
USA) with appropriate isotype controls and fluorescently
labeled secondary antibodies (Millipore, Billerica, MA,
USA). Cells were analyzed on a FACScan flow cytometer
(Becton Dickinson, Franklin Lakes, NJ, USA) to determine
the percentage of cells with positive surface proteins
and the mean fluorescence intensity. Flow cytometry
analysis was repeated for two sets of cell preparations.
The average values for percentage of positive cells and
mean fluorescence intensity were reported.
Differentiation in a laminin-rich pseudo-three-dimensional
culture system in vitro
HUCMSCs were allowed to differentiate in a laminin-rich
culture substrate previously shown to promote the forma-
tion of three-dimensional cell clusters for primary NP cells
[47]. Then 60 μl of 100% Matrigel™ (growth factor reduced
basement membrane matrix containing mainly LM-111;
BD Biosciences, San Jose, CA, USA) was coated onto 6.5
mm diameter Costar® Transwell inserts (~0.33 cm2 surface/
insert for each well of a 24-well culture plate; Corning
Incorporated Life Science, Lowell, MA, USA), and allowed
to set at 37°C for 2 hours. HUCMSCs at passage 3 were
trypsinized and seeded (3 × 106/cm2, n = 10 wells) on
top of Matrigel™ in the Transwell inserts, and then cultured
in the following three conditions: with serum-free differ-
entiation media (control = Dulbecco’s modified Eagle’smedium/Ham’s F-12 nutrient mixture + insulin–trans-
ferrin–sodium selenite, 50 μg/ml ascorbic acid, 100 nM
dexamethasone and 1% nonessential amino acids; all Life
Technologies, Grand Island, NY, USA) containing 2.5%
Matrigel™ solution (LM-111-rich matrix protein provided a
pseudo-three-dimensional condition adapted from previous
study for epithelial cell culture [48] in order to promote
more cell–laminin interactions during differentiation);
under identical conditions supplemented with insulin-like
growth factor-1 (IGF-1, 500 ng/ml; courtesy of Dr Masuda);
or under identical conditions supplemented with trans-
forming growth factor-β1 (TGF-β1, 1 ng/ml; R&D Systems,
Minneapolis, MN, USA). Cells in all three groups were
maintained at 37°C under low oxygen tension (2%)
conditions in a hypoxia chamber (a modulator incubator
chamber flushed with the hypoxic gas as described pre-
viously [49]) for 1, 7, 13 and 21 days, and the culture
medium was changed with pre-equilibrated new medium
(in the same hypoxia chamber for 24 hours) every other
day. We choose a hypoxic condition for HUCMSC dif-
ferentiation here because native NP tissue is a hypoxic
environment and hypoxic conditions are an important
environmental factor to promote differentiation of MSCs
into IVD-like cells, as indicated in a previous study [19].
Following the conclusion of each time point, cells were
harvested for histological evaluation or immunostaining
(n = 3 wells for days 1, 7 and 21), RNA isolation (n = 3
wells for days 1 and 7) and biochemistry analysis (n = 4
wells for days 0, 7, 13 and 21), as described below.
Histological evaluation for cell morphology and
proteoglycan composition
At the end of each time point, cell samples were collected
from the surface of Matrigel™ and embedded in optimum
cutting temperature medium (Sakura Finetek, Torrance,
CA, USA) and immediately flash-frozen in liquid nitrogen.
They were subsequently stored at −80°C until cryosec-
tioning. Frozen tissue sections (7 μm) were then fixed in
10% neutral buffered formalin (Azer Scientific, Morgan-
town, PA, USA) for 10 minutes, and washed in 1% lithium
carbonate solution (Mallinckrodt Chemicals, Phillipsburg,
NJ, USA) and stained with 0.5% safranin-O solution
(Sigma, St Louis, MO, USA) for 60 seconds. Samples
were rinsed with distilled water and counterstained with
Mayer’s hematoxylin (Sigma) to visualize individual cells.
After serial steps of dehydration, sections were then
mounted with Permount (Fisher Scientific, Pittsburg, PA,
USA) and visualized with light microscopy for intensity of
glycosaminoglycan staining.
Immunohistochemical staining for type II collagen
Frozen sections were processed for immunohistochemi-
cal labeling of type II collagen (HistoStain plus broad
spectrum staining kit; Invitrogen, Camarillo, CA, USA)
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ide blocking, sections were digested with pepsin (Digest-
All 3; Invitrogen) for 20 minutes at 37°C. This enzyme
helped expose the type II collagen epitope recognized by
the mouse monoclonal anti-chicken antibody (II-II6B3;
Developmental Studies Hybridoma Bank, Iowa City, IA,
USA). Following phosphate-buffered saline washing, sec-
tions were incubated with the following reagents pro-
vided in the kit: biotinylated secondary antibody (30
minutes), horseradish peroxidase-conjugated streptavidin
(30 minutes) and substrate–chromagen mixture (3-
amino-9-ethylcarbazole solution; Invitrogen, 10 minutes),
which results in a deep red color for positive staining
and visualizing the location of the antigen. Finally, sec-
tions were counterstained with Mayer’s Hematoxylin to
visualize individual cells and mounted in GVA mount-
ing medium (Sigma) for light microscopy. Negative
control sections were processed in parallel with mouse
IgG isotype control (Millipore) instead of the primary
antibody.
Immunohistochemical staining for immature nucleus
pulposus markers
Based on our previous molecular phenotype study of
immature NP cells cross three species (rat, porcine and
human) [45], laminin α5 and its specific receptor, Lu-
theran glycoprotein (CD239), other receptors for integ-
rin subunits α3, α6, β4 and β1 were selected here as
immature NP markers for evaluation of immature NP-
like cell phenotype after HUSMC differentiation. Frozen
tissue sections were fixed in 4% formaldehyde (10 mi-
nutes at room temperature) for labeling with antibodies
detecting the laminin α5 subunit and CD239. For label-
ing of integrin subunits, tissue sections were fixed in
acetone (10 minutes at −20°C). The fixed samples were
incubated with a blocking solution (3.75% bovine serum
albumin/5% goat serum; Invitrogen) for 30 minutes, and
then incubated for 2 hours with one of the following
antibodies: monoclonal or polyclonal anti-human lam-
inin α5 chain, CD239, and integrin subunits α3, α6, β4
and β1 (Table 1). Sections were washed twice in
phosphate-buffered saline and incubated with appropri-
ate secondary antibodies (AlexaFluor 488 or 633 second-
ary antibodies; Molecular Probes, Eugene, OR, USA) for
30 minutes in blocking solution. Negative control sec-
tions were incubated with appropriate isotype IgG con-
trols (mouse IgG1, IgG2a or rat IgG2a; Millipore)
instead of primary antibody, or with secondary antibody
alone as a negative control (polyclonal antibodies). All
sections were counterstained with propidium iodide (0.2
mg/ml; Sigma) to label cell nuclei, and were imaged
using confocal laser scanning microscopy (Zeiss LSM
510; 20× NA 0.5 and 63× water immersion NA 1.2 ob-
jectives; Carl Zeiss, Thornwood, NY, USA).RNA isolation and real-time RT-PCR
Total RNA was extracted from cells in each group
(control, TGF-β1 and IGF-1 treatments, n = 4) at the
end of each culture time point (1 and 7 days) with the
RNAeasy kit plus DNase I digestion (Qiagen, Valencia,
CA, USA), as described previously [50]. For quantitation
of mRNA, each target gene had two human-specific
PCR primers and one fluorescently labeled intron-
spinning probe (Applied Biosystems, Foster City, CA,
USA; Table 1). Amplification conditions were as
described previously [50]. Relative gene expression
differences were quantified amongst the control and
treatment groups at different time points using the com-
parative Ct method with β2-microglobulin as an internal
control. The relative mRNA level of the control sample
at day 1 was set as the calibrator (value = 1), and all
treatment groups at day 1 and all groups at day 7 were
normalized by this value. Duplicate PCR reactions were
performed for each target gene and the internal control
for one RNA sample. Statistical analyses were performed
to detect a difference in ΔCt values (Ct of target – Ct of
β2-microglobulin) between day 1 and day 7 samples in
each treatment group using a one-factor analysis of
variance (ANOVA) (StatView; SAS Institute, Cary, NC,
USA) followed by Tukey’s post-hoc analysis at a signifi-
cant level of 0.05 (n = 3). Fold-differences of relative
mRNA level (2–ΔΔCt) between day 1 and day 7 samples
in each treatment group were reported if ≥2, and where
ANOVA detected a difference at P < 0.05 [50].
Sulfated glycosaminoglycan production
Differentiated HUCMSC production of sulfated glyco-
saminoglycans (sGAGs) was analyzed using the
dimethylmethylene blue spectrophotometric method
[51]. All samples were digested in papain solution (300
μg/ml in phosphate-buffered saline with 5 mM ethyl-
enediaminetetraacetic acid and 5 mM cysteine; Sigma)
at 65°C for 16 hours, then vortexed, and stored at
−20°C. sGAG content was measured by mixing an aliquot
(40 μl) of digested samples with dimethylmethylene blue
dye solution (125 μl, 21 μg/ml, pH 3; two replicates
per sample) in a 96-well assay plate and measuring ab-
sorbance (535 nm) on a plate reader (Tecan Genios,
Mannendorf, Switzerland). sGAG concentrations were
calculated from the absorbance using a standard curve
prepared from commercial chondroitin-4-sulfate (Sigma).
Total sGAG per sample was then normalized to DNA
content (Quant-iT PicoGreen dsDNA Kit; Life Techno-
logies) for each sample. Differences in sGAG production
(sGAG/DNA) amongst control and treatment groups at
each time point were evaluated via one-factor ANOVA,
followed by Tukey’s post-hoc analysis at a significance level
of 0.05 (n = 4).
Table 1 PCR Probes and primers of nucleus pulposus markers and corresponding antibodies for immunostaining for
protein expression
Target PCR probe/primers Antibody
Order number Vendor (order number) Host/type
Aggrecan Hs 00153936_m1 NA NA
Type II collagen Hs 00156568_m1 Developmental Studies Hybridoma Bank, University of Iowa,
Iowa City, IA, USA (II-II6B3)
Ms/monoclonal
Integrin α3 Hs 01076873_m1 Chemicon, Temecula, CA, USA (AB1920) Rb/polyclonal
Integrin α6 Hs 00173952_m1 BD Biosciences, San Jose, CA, USA (555734) Rat/monoclonal
Integrin β4 Hs 00173995_m1 Chemicon (AB1922) Rb/polyclonal
CD239 (Lu) Hs 00170663_m1 AbD Serotec, Oxford, UK (MCA1982) Ms/monoclonal
Laminin α5 NA Chemicon (MAB1924) Ms/monoclonal
Probes and primers from Applied Biosystems (Foster City, CA, USA) of nucleus pulposus markers analyzed by real-time PCR and corresponding antibodies used for
immunostaining for protein expression of these markers. Rb, rabbit; Ms, mouse; NA, not applicable; Lu, Lutheran glycoprotein.
Figure 1 Morphological features of undifferentiated/
differentiated human umbilical cord mesenchymal stromal
cells cultured on different surfaces. (A) Undifferentiated cells
were characterized by a fibroblast-like cell morphology during
proliferation on a tissue culture polystyrene surface. (B)
Differentiated cells formed a cell-clustering structure (arrow) in
a Matrigel™-coated Transwell insert following culture in a
pseudo-three-dimensional system for 21 days. (C) Differentiated
cells showed morphology with stress fibers on a 0.1% gelatin
solution-coated hard surface. (D) In comparison, differentiated cells
formed a cluster structure on a 100% Matrigel™ soft surface
(see high-magnification insert in (D)). (C), (D) Cells were seeded on
the wells of glass chamber slides precoated with 0.1% gelatin
solution to improve cell attachment on the glass surface or 100%
Matrigel™ to create a soft gel surface for cell clustering behavior
respectively. They were cultured for up to 7 days, then fixed and
stained for actin distribution by fluorescein isothiocyanate–phalloidin
(green). Cell nuclei were counterstained with propidium iodide (red).
Scale bars = 50 μM.
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As described above, all papain-digested samples were
thawed and vortexed prior to undergoing collagen content
analysis according to the instruction of the Sircol Collagen
Assay Kit (Biocolor, Carrickfergus, UK). Digested samples
were incubated with the Sircol Dye reagent for 30 minutes,
where each sample was gently mixed every 5 minutes.
Samples were then centrifuged at 10,000×g for 10 minutes
to collect the collagen-bound dye. Following supernatant
removal, the pellet was resuspended in the Alkali reagent
and transferred to a 96-well assay plate for measuring
absorbance (535 nm) on a plate reader (Tecan Genios)
with the total collagen content calculated using a standard
curve. Two duplicate wells were measured for each sample,
and each collagen content value was normalized to DNA
content (as described above) for each sample. Differences
in total collagen production (collagen/DNA) amongst
control and treatment groups at each time point were
evaluated via one-factor ANOVA, followed by Tukey’s
post-hoc analysis at a significance level of 0.05 (n = 4).
Results
Expression of cell surface receptors in undifferentiated
HUCMSCs
Undifferentiated HUCMSCs exhibited fibroblast-like mor-
phology (Figure 1A) during proliferation on a tissue culture
plastic surface. They expressed typical MSC markers, such
as CD44, CD29, CD90, CD105 and CD166 (Table 2), but
were negative for CD45, CD34 and CD31 (Table 2). Based
on flow cytometry analysis, 98 to 99% of cells were positive
for these MSC markers regardless of cell passage number
(at passage 3 or passage 5), except for CD105 (75% positive
cells at passage 3 and 25% at passage 5) (Table 2). Undif-
ferentiated HUCMSCs also showed expression of many
laminin–related cell surface receptors, such as Lutheran
glycoprotein (CD239), integrin subunit α3 (CD49c) and
α6 (CD49f), but not integrin β4 (CD104) (Table 2). Inter-
estingly, limited passages (passage 3 to passage 5) did not
Table 2 Undifferentiated HUCMSCs express cell surface
markers typical to MSCs and immature nucleus pulposus
cells
Passage 3 Passage 5
Target % (+) cells MFI % (+) cells MFI
CD44 99 2758 99 917
CD90 99 366 99 120
CD166 98 216 99 53
CD105 75 16 26 9
CD29 (ITGβ1) 99 215 99 692
CD49c (ITGα3) 99 127 99 211
CD49f (ITGα6) 63 34 0 0
CD104 (ITGβ4) 1 12 2 2
CD239 (Lu) 30 17 82 32
CD34 0 0 0 0
CD31 0 0 1 1
CD45 0 0 0 0
Values represented a mean of duplicate samples (n = 2). %(+), percentage of
total number of cells expressing the markers. HUCMSC, human umbilical cord
mesenchymal stromal cell; ITG, integrin; Lu, Lutheran glycoprotein; MFI, mean
fluorescence intensity; MSC, mesenchymal stem cell.
Data were obtained via flow cytometry analysis.
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α6 being an exception. The expression of integrin α6
could not be detected in cells at passage 5 (Table 2). Only
passage 3 cells were therefore used for the following cell
differentiation study.
Pseudo-three-dimensional culture of human umbilical
cord mesenchymal stromal cells
Cell morphology in differentiation
A pseudo-three-dimensional culture condition (LM-111
rich, Matrigel™) promotes HUCMSC differentiation under
no serum conditions. Between days 1 and 7 of culture on
Matrigel™, HUCMSCs demonstrated a cell clustering
morphology (Figure 1D) similar to that of immature
NP cells in situ [52] and of primary immature NP cells
within a similar laminin-rich culture system [47]. In com-
parison, HUCMSCs on a 0.1% gelatin solution-coated hard
surface showed a flattened morphology with stress fibers
(actin stained by fluorescein isothiocyanate–phalloidin)
(Figure 1C). This suggests that the Matrigel™ culture sys-
tem promoted HUCMSC clustering as we have observed
with primary NP cells. By the end of 21 days, differentiated
cells in control and two treatment groups (TGF-β1, IGF-1)
had all formed gelatinous structures in the pseudo-three-
dimensional laminin-rich culture system (Figure 1B).
Gene expression of nucleus pulposus markers
To monitor HUCMSC differentiation towards an NP-like
phenotype, gene expression of NP-related ECM proteins
and laminin receptors was analyzed via real-time PCR atdays 1 and 7. Differentiated HUCMSCs expressed variable
mRNA levels of NP markers at day 7 compared with that
at day 1. For ECM proteins, mRNA levels of aggrecan
appeared to increase from day 1 to 7 in the TGF-β1 treat-
ment group (Figure 2A and Table 3), but the fold-increase
was not considered statistically significant (Figure 2A and
Table 3; P >0.05, ANOVA). No increase in mRNA levels
was detected for type II collagen in any experimental group
from day 1 to day 7 (Figure 2B). For integrin subunits,
mRNA levels of integrins α3 and β4 increased from day 1
to day 7 for cells in all groups (Figure 2D,E), but only cells
in both TGF-β1 and IGF-1 treatment groups exhibited
statistically significant increases in integrins α3 and β4
(Figure 2D,E and Table 3; ≥2-fold, P <0.05, ANOVA).
mRNA levels of CD239 and integrin α6 were decreased
from day 1 to day 7 in all experimental groups (Figure 2C,F),
with only the reduction in CD239 expression being statis-
tically significant (Table 3 and Figure 2F; ≥2-fold, P <0.05,
ANOVA).
Glycosaminoglycan and collagen synthesis
Safranin-O staining and sGAG production were maintained
in all cells cultured up to 21 days (Figure 3). No difference
in safranin-O staining was observed amongst two growth
factor treatment groups and control group at any time
point (Figure 3A). By the end of day 21, however, both
TGF-β1 and IGF-1 treatment groups exhibited signifi-
cantly elevated levels of total sGAG/DNA, as compared
with that in the control group (Figure 3B; P <0.05,
ANOVA).
Differentiated HUCMSCs from all experimental groups
stained intensely for type II collagen at day 21 (Figure 4A).
An increase of staining intensity was observed across
all treatment groups and control from day 7 to day 21,
but almost no positive staining appeared at day 1 for all
groups (Figure 4A). Total collagen/DNA contents were
maintained in all cells cultured up to 21 days (Figure 4B).
There was no difference for total collagen/DNA contents
observed amongst two growth factor treatment groups
and control at day 7 and day 21 (Figure 4B). However,
at day 13 cells from the IGF-1 treatment group showed
significant increases in total collagen/DNA content relative
to the control and TGF-β1 treatment group (Figure 4B;
P <0.05, ANOVA).
Protein expression of nucleus pulposus markers
After 21 days in culture, differentiated HUCMSCs from
all experimental groups stained positively for the laminin
α5 chain (Figure 5A), although protein expression of the
laminin α5 receptor (CD239) was not detected in any group
(Figure 5B). Protein expression of integrins in differentiated
HUCMSCs was maintained for both α3 and β4 subunits
(Figure 5C,E) but no expression of the α6 subunit was
detected in any group (Figure 5D). No difference in
Figure 2 Gene expression levels varied in human umbilical cord mesenchymal stromal cells during early differentiation. Gene
expression levels were measured via real-time RT-PCR. Relative mRNA fold-changes (2–ΔΔCt) for extracellular matrix proteins ((A) aggrecan, (B) type
II collagen) and laminin receptors (integrin subunits: (C) ITGα6, (D) α3, (E) β4 and (F) CD239) in differentiated human umbilical cord
mesenchymal stromal cells cultured on a three-dimensional Matrigel™ system for 1 and 7 days (n = 4, mean ± standard error). The relative mRNA
level of the control sample at day 1 was set as the calibrator (value = 1) for normalizing the relative mRNA levels of treatment groups at day 1
and all groups at day 7 (a, fold-difference between day 1 and day 7 samples of each treatment group ≥2, P <0.05, one-factor analysis of variance
followed by Tukey’s post-hoc analysis). IGF-1, insulin-like growth factor-1; TGF, transforming growth factor.
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served amongst the two growth factor treatment groups
and control (Figure 5).
Discussion
The goal of this research was to explore suitable envir-
onmental conditions to promote the differentiation of
HUCMSCs into cells with an immature NP-like pheno-
type. These conditions were designed by growing cells in a
pseudo-three-dimensional environment using Matrigel™Table 3 ΔCt values for target genes (target Ct – β2-microglob
Sample Aggrecan Collagen II ITGα6
Control
Day 1 21.1 ± 0.7 17.6 ± 0.2 14.6 ±
Day 7 23.4 ± 0.3 18.3 ± 0.3 16.1 ±
TGF-β1
Day 1 19.8 ± 0.4 18.0 ± 0.8 15.5 ±
Day 7 18.9 ± 0.4 17.3 ± 0.7 16.9 ±
IGF-1
Day 1 20.0 ± 0.5 16.8 ± 0.6 15.0 ±
Day 7 19.8 ± 0.5 18.0 ± 0.7 15.8 ±
Values represent mean ± standard deviation of all RT-PCR replicates for n = 4 RNA
follows: ΔCt values of control at day 1 are subtracted from ΔCt values of control at d
ΔΔCt and the fold-difference of relative mRNA levels (2–ΔΔCt) for each target as illust
transforming growth factor.
aFold-difference between day 1 and day 7 samples ≥2 and P <0.05, one-factor analas a laminin-rich extracellular matrix environment alone or
with the addition of the growth factors IGF-1 and TGF-β1,
and using hypoxic conditions. This study demonstrated that
HUCMSCs have some potential to differentiate into cells
sharing features with immature NP cells within a laminin-
rich pseudo-three-dimensional culture environment. Our
results indicated that HUCMSCs not only formed matrix
similar to that of NP cells, but also expressed some imma-
ture NP cell markers during differentiation. Extracellular
matrix protein (collagen II, laminin α5), glycosaminoglycansulin Ct)
ITGα3 ITGβ4 CD239
1.0 8.7 ± 1.0 11.2 ± 0.5 13.3 ± 0.4
0.9 7.4 ± 0.4 10.6 ± 0.3 14.7 ± 0.5a
0.2 9.9 ± 0.2 11.3 ± 0.2 13.3 ± 0.2
0.9 7.7 ± 0.5a 9.6 ± 0.4a 14.7 ± 0.5a
0.9 9.1 ± 0.6 11.0 ± 0.2 12.8 ± 0.3
0.2 7.1 ± 0.4a 10.0 ± 0.4a 14.6 ± 0.5a
samples. Control values (in bold) at day 1 are used to normalize all data as
ay 7 or ΔCt values of each treatment group at both day 1 and day 7 to obtain
rated in Figure 2. IGF-1, insulin-like growth factor-1; ITG, integrin; TGF,
ysis of variance followed by Tukey’s post-hoc analysis.
Figure 3 Glycosaminoglycan production detected in the
differentiated human umbilical cord mesenchymal stromal cells
cultured in Matrigel™. Human umbilical cord mesenchymal
stromal cells were cultured for 1 to 21 days in a three-dimensional
Matrigel™ system. (A) Histological staining for proteoglycan by
safranin O (n = 4, only one represented image shown; scale bar = 50
μm). (B) Sulfated glycosaminoglycan production normalized to DNA
content (sGAG/DNA, n = 4, mean ± standard error) in cells (a,
significant difference was detected between either treatment groups
and control at day 21 only, one-factor analysis of variance, followed
by Tukey’s post-hoc analysis, P < 0.05). IGF-1, insulin-like growth
factor-1; TGF, transforming growth factor.
Figure 4 Total collagen production and type-II collagen protein
in the differentiated human umbilical cord mesenchymal
stromal cells cultured in Matrigel™. Human umbilical cord
mesenchymal stromal cells were cultured for 1 to 21 days in a three-
dimensional Matrigel™ system. (A) Immunostaining for type II
collagen (Col II) (n = 4, only the represented image shown; scale bar =
50 μm). (B) Total collagen content normalized to DNA (collagen/DNA,
n = 4, mean ± standard error) in cells (a, significant difference was
detected between IGF-1 treatment group and control at day 13 only,
one-factor analysis of variance, followed by Tukey’s post-hoc analysis,
P <0.05). IGF-1, insulin-like growth factor-1; TGF, transforming
growth factor.
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lene blue assay) and some laminin receptor protein ex-
pression (integrin α3 and β4 subunit) were detected in
differentiated cells under all culture conditions. These
expression patterns of the laminin isoform and its recep-
tors are similar to that in immature NP tissue in situ, as
we reported previously [45]. These finding suggest that
the soft Matrigel™ culture system was directly responsible
for regulating HUCMSC differentiation here. As early as
24 hours post seeding, these cells were shown to cluster in
a manner akin to that of both immature NP cells in situ
and primary immature NP cells cultured in a similar
laminin-rich culture system [47]. These observations
suggest that the laminin-rich pseudo-three-dimensional
culture system here provided HUCMSCs with a suitable
microenvironment similar to that of the native NP tissueincluding the presence of free laminin ligand and soft
mechanical properties for the substrate.
ECM interaction with cells is well known to play an
important role in stem cell differentiation [53]. Previously,
laminin was found to enhance adult MSC differentiation
to adipocytes [54] and human embryonic stem cell differ-
entiation into neurons [55]. It is also known that substrate
stiffness affects the fate of stem cell differentiation [56].
Our previous study revealed that mechanical proper-
ties of Matrigel™ are in a range spanning that of the
gelatinous-like NP tissue. Indeed, immature NP primary
cells maintained a clustered morphology when they were
cultured on this Matrigel™ substrate [47]. We believe that
this soft substrate also promotes and maintains clustered
cell morphology during HUCMSC differentiation in the
current study. Nevertheless, our results highlighted the
Figure 5 Differentiated human umbilical cord mesenchymal
stromal cells expressed nucleus pulposus cell markers.
Immunostaining for (A) the laminin (LM) α5 chain and receptors,
(B) CD239, (C) integrin subunit α3, (D) integrin subunit α6 and
(E) integrin subunitβ4 in differentiated human umbilical cord
mesenchymal stromal cells cultured for 21 days (green = target;
red = cell nuclei counterstained with propidium iodide; bar = 50 μm).
IGF-1, insulin-like growth factor-1; TGF, transforming growth factor.
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stiffness on HUCMSCs differentiation into immature
NP-like cells in vitro.
It is noteworthy that not all NP-associated laminin
receptors were maintained in differentiated HUCMSCs
at the end of the culture time (21 days). The integrin
α6 subunit that forms a complex with the β4 subunit
and CD239, a laminin α5 subunit-specific receptor, were
unexpectedly absent in differentiated cells in the control
group and two treatment groups. However, LM-511 and
its receptors (integrin α3, integrin β4) were highly
expressed in all differentiated cells at day 21 (Figure 5).
The differential expression of receptor types at the protein
levels appeared to be reflected in their mRNA levels
during differentiation. It was noted that the gene ex-
pression levels of integrins α3 and β4 were elevated
while the gene expression levels of integrin α6 and
CD239 were decreased from day 1 to day 7 for cells in all
groups. It is possible that LM-111, the major component
of Matrigel™, only promotes the expression of integrinsreceptors but not the non-integrin receptor, CD239. In a
future study, a LM-511 supplement may be required to
promote expression of the specific receptor CD239 in dif-
ferentiated cells.
Growth factors provide molecular signaling and cues that
promote cells to differentiate along specific pathways from
an undifferentiated state to a differentiated state. Two
growth factors that seem particularly important for differ-
entiation towards IVD-like cells are IGF-1 and TGF-β1.
IGF-1 and its receptor have been shown to be expressed
in the IVD [57,58], and IGF-1 has been shown to have an
effect on early dorso-anterior (notochord) development
[59] and to promote chondrocyte differentiation and em-
bryonic bone development [60]. Members of the TGF-β
family and receptors are expressed in the IVD [57,58], and
TGF-β1 was reported to be able to induce rat MSCs to
differentiation to a phenotype consistent with NP on
alginate hydrogels [19]. However, supplementation
with either IGF-1 (500 ng/ml) or TGF-β1 (1 ng/ml) did
not generate distinct differences in NP-like cell types in
the current study; although sGAG content was enhanced
at day 21 of culture in both growth factor treatment
groups relative to the control of Matrigel™ alone. Similarly,
total collagen content was significantly elevated at day 13
in IGF-1 treated group. Furthermore, we selected a special
form of Matrigel™ with relative lower growth factor
residuals (BD Biosciences) for this study to minimize the
possible interference from the endogenous growth factors
in Matrigel™. Together, our finding may imply that the
laminin matrix niche, substrate softness and three-
dimensional culture, but not growth factors, are more
critical factors in stimulating HUCMSC differentiation
toward an immature NP-like phenotype in the Matrigel™
system. Future studies with various concentrations of
growth factor supplements and using different ECM
matrixes (such as collagen or agarose) as well as no
matrix as possible controls are needed to confirm these
new findings. In addition, a larger sample size may be
needed to statistically reveal a greater benefit of using
growth factors.
Although the differentiated HUCMSCs developed a
shape similar to that of the NP cells, the final tissue
constructs (cell clusters) were quite small. Larger cell
clusters could be made by increasing the number of
HUCMSCs during initial seeding with some important
benefits. First, cells could be differentiated into a cell
structure that truly resembles the NP and that could
potentially replace damaged NP in the future. Second,
larger cell clusters could be used to analyze the mechan-
ical properties of the HUCMSC cell cluster. In preliminary
tests, we attempted to measure shear stress using a
rheometer. Unfortunately, the cell clusters were too small
to measure significant values for shear stiffness in bulk.
Larger cell clusters would allow for the measurement
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constructs will provide quantitative data to test whether
formed HUCMSC clusters are adopting a gelatinous
immature NP-like phenotype.
Conclusions
Our study demonstrates that HUCMSCs have the potential
to differentiate into cells sharing features with immature
NP cells within a laminin-rich pseudo-three-dimensional
culture system. Differentiated HUCMSCs not only formed
a gelatinous cell clustering structure and produced matrix
proteins (collagen II, laminin α5) and sGAGs similar
to that of immature NP cells, but also expressed some
immature NP cell markers (laminin receptors: integrin
α3 and β4 subunit). Growth factor treatments had no
effect on the expressions of immature NP markers in
the differentiated HUCMSCs.
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